Credit Agricole’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Credit Agricole's ARKG Position: Q2 2026 in Review
Credit Agricole sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 8,664 shares — an estimated $229K sold.
Credit Agricole first reported a position in ARKG in Q3 2024 and held it in 4 quarters. The position peaked at $970K in Q1 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Credit Agricole reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
- Credit Agricole sold 8,664 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $229K.
- Credit Agricole first reported a position in ARK Genomic Revolution ETF in Q3 2024 and held it in 4 quarters.
- Credit Agricole's ARK Genomic Revolution ETF position peaked at $970K in Q1 2025.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.